AbbVie (ABBV) February weekly 165 straddle into quarter results
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $229.73 +6.12%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +8.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +8.8%
Join SI Premium – FREE
AbbVie (NYSE: ABBV) February weekly 165 straddle priced for a move of 3.5% into the expected release of quarter results before the bell on February 2.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AbbVie (ABBV) call put ratio 2.2 calls to 1 put into near deal to acquire Apogee Therapeutics (APGE), FT reports
- Carnival Corp. (CCL) call put ratio 1 call to 1.4 puts into quarter results
- NewAmsterdam Pharma (NAMS) call put ratio 1 call to 4.8 puts with a focus on 2K contracts of January 25 puts
Create E-mail Alert Related Categories
Option EPS Action, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
